Sex Reassignment Surgery Market
Request Sample     Request discount  

Global Sex Reassignment Surgery Market Share, Size, Trends, Industry Analysis Report, By Gender Transition, By End-Use; By Region, Segment Forecast, 2024- 2031

  • Published Date : 2024-09-18
  • Pages : 100
  • Report Id : 40446
  • Categories : Healthcare

This report describes the global market size of Sex Reassignment Surgery from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 31.6% from 2024 to 2031.

Due to the COVID-19 pandemic, the global market for Sex Reassignment Surgery estimated at US 8.4 $ billion in the year 2023, is projected to reach a revised size of US 111.718 $ million by 2031, growing at a CAGR of 31.6% during the forecast period 2024-2031.

Sex reassignment surgery (SRS) is a set of surgical procedures that align an individual's physical characteristics with their gender identity. This includes surgeries such as vaginoplasty or phalloplasty, depending on whether the person is transitioning from male to female or female to male. SRS is typically part of a broader transition process that may also include hormone therapy and psychological support. The goal is to improve the individuals quality of life and alleviate gender dysphoria by achieving physical congruence with their gender identity.

For geography segment, regional supply, demand, major players, price is presented from 2019 to 2031. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America


The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Sex Reassignment Surgery as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share

By Type of Procedure
Male-to-Female (MTF) Surgery
Vaginoplasty
Breast Augmentation
Facial Feminization Surgery
Female-to-Male (FTM) Surgery
Top Surgery (Chest Reconstruction)
Phalloplasty
Metoidioplasty

Sex reassignment surgery (SRS) encompasses a range of procedures tailored to align physical characteristics with an individual's gender identity. In Male-to-Female (MTF) surgery, key procedures include vaginoplasty, which constructs a neovagina, enabling sexual function and alignment with female anatomy. Breast augmentation is performed to develop a more traditionally feminine chest contour, while facial feminization surgery involves various techniques to reshape facial features, enhancing overall feminine appearance and congruence. For Female-to-Male (FTM) surgery, top surgery or chest reconstruction involves removing breast tissue to create a masculine chest profile. Phalloplasty is a complex procedure that constructs a neopenis using grafted tissue, enabling sexual function and appearance. Metoidioplasty, an alternative to phalloplasty, uses existing genital tissue to create a phallus and may include the addition of a urethra for urination. Each procedure is customized to address individual needs and goals, aiming to reduce gender dysphoria and improve the quality of life for transgender individuals.

By Gender
Male-to-Female
Female-to-Male

Sex reassignment surgery (SRS) involves procedures tailored to align physical characteristics with an individual's gender identity, divided into Male-to-Female (MTF) and Female-to-Male (FTM) categories. For Male-to-Female transitions, surgeries typically include vaginoplasty, which constructs a neovagina for sexual function and anatomical congruence; breast augmentation to develop a feminine chest contour; and facial feminization surgery, which reshapes facial features to achieve a more traditionally feminine appearance. In Female-to-Male transitions, procedures focus on masculinizing the body and include top surgery (chest reconstruction), which removes breast tissue to create a masculine chest; phalloplasty, which constructs a neopenis from grafted tissue, allowing for sexual function; and metoidioplasty, which uses existing genital tissue to create a phallus and may include urethral reconstruction for urination. Each type of surgery is designed to enhance physical alignment with gender identity and improve the individual's overall well-being.

By Type of Medical Professional
Surgeons
Endocrinologists
Psychiatrists/Psychologists

Sex reassignment surgery (SRS) involves a multidisciplinary team of medical professionals, each playing a crucial role in the process. Surgeons are directly responsible for performing the various surgical procedures associated with SRS. They specialize in techniques specific to Male-to-Female (MTF) and Female-to-Male (FTM) surgeries, such as vaginoplasty, phalloplasty, and chest reconstruction, ensuring the procedures align with the patient's gender identity goals and medical needs. Endocrinologists manage hormone therapy, which is often a critical component of the transition process. They prescribe and monitor hormone treatments that help develop secondary sexual characteristics consistent with the individual's gender identity, such as breast growth or facial hair. Their role is essential in preparing the body for surgery and maintaining long-term health post-operatively. Psychiatrists/Psychologists provide crucial support throughout the transition process. They offer pre-surgical assessments to confirm readiness for surgery, help manage any mental health concerns, and support the patient in coping with the emotional aspects of transitioning. Their involvement is key in ensuring that the individual is mentally prepared and resilient, contributing to better overall outcomes in the transition journey.


By End User
Hospitals
Specialty
Clinics
Others

Sex reassignment surgery (SRS) is performed across various healthcare settings, each catering to different aspects of the process. Hospitals often offer comprehensive SRS services, including pre-operative assessments, the surgeries themselves, and post-operative care, benefiting from their extensive facilities and specialist teams. Specialty clinics focus specifically on gender-affirming surgeries and related care, providing expertise and tailored services for both Male-to-Female (MTF) and Female-to-Male (FTM) transitions. These clinics may offer a more personalized approach and dedicated support for the transition process. General clinics also provide SRS, especially those with a focus on transgender health. They might handle pre-surgical consultations and post-operative follow-ups, often collaborating with surgical centers for the actual procedures. Additionally, other medical centers, such as academic institutions and private practices, may offer SRS services as part of their broader healthcare offerings. These centers contribute by providing specialized care and research opportunities, enhancing accessibility and options for individuals seeking gender-affirming surgery. Together, these end users ensure comprehensive, accessible, and specialized care for those undergoing sex reassignment surgery.


Key Players
Cleveland Clinic
Mayo Clinic
Johns Hopkins Medicine
Massachusetts General Hospital
Stanford Health Care
The Gender Confirmation Center
Chrysalis Health
Beverly Hills Plastic Surgery
Dr. Toby Meltzer
Dr. Sherman Leis

Please ask for sample pages for full companies list

Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031

Any special requirements about this report, please let us know and we can provide custom report.


TABLE OF CONTENTS

Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1.Sex Reassignment Surgery Outlook
3.1.2.Sex Reassignment Surgery Overview
3.2. Effect of Covid - 19 Impact
3.3. Macro - Economic Overview
3.3.1. GDP Growth
3.3.2. Retail Industry Growth
3.4. Pricing Analysis
3.5. Challenges related to adoption of Sex Reassignment Surgery
3.6. Regulations of Sex Reassignment Surgery
3.7. Forecast Factors: Relevance and Impact
3.8. Market Dynamics
3.8.1. Drivers
3.8.2. Restraints
3.8.3. Opportunity
3.8.4. Trends
3.8.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y - o - Y Projections
4.4. Absolute Opportunity Analysis
5. Global Sex Reassignment Surgery Value Chain Analysis
5.1.Sex Reassignment Surgery Value Chain
5.1.1. List of Raw Material Suppliers
5.1.2. List of Sex Reassignment Surgery Manufacturers
5.1.3. List of Segment
6. Global Sex Reassignment Surgery Analysis By Type of Procedure
6.1. Introduction
6.1.1. Market Value Share Analysis By Type of Procedure
6.1.2. Y - o - Y Growth Analysis By Type of Procedure
6.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Type of Procedure
6.3. Market Attractiveness Analysis Age Group
7. Global Sex Reassignment Surgery Analysis By Gender
7.1. Introduction
7.1.1. Market Value Share Analysis By Gender
7.1.2. Y - o - Y Growth Analysis By Gender
7.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Gender
7.3. Market Attractiveness Analysis By Gender
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Type ion Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Technology Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1. Cleveland Clinic
9.2.1.1. Overview
9.2.1.2. Type Portfolio
9.2.1.3. Financial Overview
9.2.2. Mayo Clinic
9.2.2.1. Overview
9.2.2.2. Type Portfolio
9.2.2.3. Financial Overview
9.2.3. Johns Hopkins Medicine
9.2.3.1. Overview
9.2.3.2. Type Portfolio
9.2.3.3. Financial Overview
9.2.4. Massachusetts General Hospital
9.2.4.1. Overview
9.2.4.2. Type Portfolio
9.2.4.3. Financial Overview
9.2.5. Stanford Health Care
9.2.5.1. Overview
9.2.5.2. Type Portfolio
9.2.5.3. Financial Overview
9.2.6. The Gender Confirmation Center.
9.2.6.1. Overview
9.2.6.2. Type Portfolio
9.2.6.3. Financial Overview
9.2.7. Chrysalis Health
9.2.7.1. Overview
9.2.7.2. Type Portfolio
9.2.7.3. Financial Overview
9.2.8.Beverly Hills Plastic Surgery
9.2.8.1. Overview
9.2.8.2. Type Portfolio
9.2.8.3. Financial Overview
9.2.9. Dr. Toby Meltzer
9.2.9.1. Overview
9.2.9.2. Type Portfolio
9.2.9.3. Financial Overview
9.2.10. F. Dr. Sherman Leis
9.2.10.1. Overview
9.2.10.2. Type Portfolio
9.2.10.3. Financial Overview
9.2.11. COMPANY11
9.2.11.1. Overview
9.2.11.2. Type Portfolio
9.2.11.3. Financial Overview
9.2.12. COMPANY12
9.2.12.1. Overview
9.2.12.2. Type Portfolio
9.2.12.3. Financial Overview
9.2.13. COMPANY13
9.2.13.1. Overview
9.2.13.2. Type Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY14
9.2.14.1. Overview
9.2.14.2. Type Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY15
9.2.15.1. Overview
9.2.15.2. Type Portfolio
9.2.15.3. Financial Overview
10. Global Sex Reassignment Surgery Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y - o - Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia - Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023 - 2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia - Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America Sex Reassignment Surgery Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Type of Procedure
11.5. Current Market Size (USD Mn) Forecast 2023 - 2030 By Type of Procedure
11.6. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Gender
11.7. Current Market Size (USD Mn) Forecast 2023 - 2030 By Gender
12. South America Sex Reassignment Surgery Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Type of Procedure
12.6. Current Market Size (USD Mn) Forecast 2023 - 2030 By Type of Procedure
12.7. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Gender
12.8. Current Market Size (USD Mn) Forecast 2023 - 2030 By Gender
13. Europe Sex Reassignment Surgery Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Type of Procedure
13.6. Current Market Size (USD Mn) Forecast 2023 - 2030 By Type of Procedure
13.7. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Gender
13.8. Current Market Size (USD Mn) Forecast 2023 - 2030 By Gender
14. Middle East and Africa Sex Reassignment Surgery Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia - Pacific Sex Reassignment Surgery Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018 - 2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia - Pacific
15.4. Current Market Size (USD Mn) Forecast 2023 - 2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia - Pacific
i. Research Methodology
ii. Assumptions & Acronyms


LIST OF FIGURES

Figure 01: Global Sex Reassignment Surgery, BPS Analysis,By Type of Procedure, 2018(H), 2023(E) & 2030(F)
Figure 02: Global Sex Reassignment Surgery, Y - O - Y Growth,By Type of Procedure, 2020(A) - 2030(F)
Figure 03: Global Sex Reassignment Surgery Attractiveness Analysis, By Type of Procedure (2020)
Figure 04: Global Sex Reassignment Surgery, BPS Analysis, By Gender, 2018(H), 2023(E) & 2030(F)
Figure 05: Global Sex Reassignment Surgery, Y - O - Y Growth, By Gender, 2018(H) - 2030(F)
Figure 06: Global Sex Reassignment Surgery Attractiveness Analysis, By Gender
Figure 07: Global Sex Reassignment Surgery, Value Analysis, By Type of Procedure, 2018(H) - 2030(F)
Figure 08: Global Sex Reassignment Surgery, Value Analysis, by By Gender, 2018(H) - 2030(F)
Figure 09: Global Sex Reassignment Surgery, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global Sex Reassignment Surgery, Y - O - Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global Sex Reassignment Surgery Attractiveness Analysis, by Region
Figure 12: North America Sex Reassignment Surgery Value (USD Mn Forecast, 2018 2022
Figure 13: North America Sex Reassignment Surgery Value (USD Mn Forecast, 2023 2030
Figure 14: South America Sex Reassignment Surgery Value (USD Mn) Forecast, 2018 2022
Figure 15: South America Sex Reassignment Surgery Value (USD Mn) Forecast, 2023 2030
Figure 16: Europe Sex Reassignment Surgery Value (USD Mn) Forecast, 2018 2022
Figure 17: Europe Sex Reassignment Surgery Value (USD Mn) Forecast, 2023 2030
Figure 18: Middle East and Africa Sex Reassignment Surgery Value (USD Mn) Forecast, 2018 2022

LIST OF TABLES

Table 01: Global Sex Reassignment Surgery Value (USD Mn) Forecast, By Type of Procedure, 2018(H) 2030(F)
Table 02: Global Sex Reassignment Surgery Value (USD Mn) Forecast, By Gender, 2018(H) 2030(F)
Table 03: Global Sex Reassignment Surgery Value (USD Mn) Forecast, By Country, 2018(H) 2030(F)
Table 04: North America Sex Reassignment Surgery Value (USD Mn) Forecast, by Country, 2018(H) 2030(F)
Table 05: North America Sex Reassignment Surgery Value (USD Mn) Forecast,By Type of Procedure, 2018(H) 2030(F)
Table 06: North America Sex Reassignment Surgery Value (USD Mn) Forecast, By Gender, 2018(H) 2030(F)
Table 07: South America Sex Reassignment Surgery Value (USD Mn) Forecast, By Country, 2018(H) 2030(F)
Table 08: South America Sex Reassignment Surgery Value (USD Mn) Forecast,By Type of Procedure, 2018(H) 2030(F)
Table 09: South America Sex Reassignment Surgery Value (USD Mn) Forecast, By Gender, 2018(H) 2030(F)
Table 10: Europe Sex Reassignment Surgery Value (USD Mn) and Forecast, by Country, 2018(H) 2030(F)
Table 11: Europe Sex Reassignment Surgery Value (USD Mn) Forecast, By Type of Procedure, 2018(H) 2030(F)
Table 12: Europe Sex Reassignment Surgery Value (USD Mn) Forecast, By Gender EndUser, 2018(H) 2030(F)
Table 13: Middle East and Africa Sex Reassignment Surgery Value (USD Mn) Forecast, By Country, 2018(H) 2030(F)
Table 14: Middle East and Africa Sex Reassignment Surgery Value (USD Mn) Forecast, By Type of Procedure, 2018(H) 2030(F)
Table 15: Middle East and Africa Sex Reassignment Surgery Value (USD Mn) Forecast, By Gender, 2018(H) 2030(F)
Table 16: Asia - Pacific Sex Reassignment Surgery Value (USD Mn) Forecast, by Country, 2018(H) 2030(F)
Table 17: Asia - Pacific Sex Reassignment Surgery Value (USD Mn) Forecast, By Type of Procedure, 2018(H) 2030(F)
Table 18: Asia - Pacific Sex Reassignment Surgery Value (USD Mn) Forecast, By Gender, 2018(H) 2030(F)


Immediate acquisition
Your strategic edge begins with Stats and Research
Single User License
$3490
It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.
Multi User License
$5240
It allows the purchased product to be shared among 1-5 employees of your organization within same geographical location.
Enterprise User License
$6990
It allows the purchased product to be shared among all employees of your organisation irrespective of their geographical location.

Global Albumin Market

Global Albumin Market

Global Surgical Equipment Market

Global Surgical Equipment Market

Global Interventional Oncology Market

Global Interventional Oncology Market

Global Brain-Computer Interface (BCI) Market

Global Brain-Computer Interface (BCI) Market

Europe Hormone Replacement Therapy Market

Europe Hormone Replacement Therapy Market

Global Medical Tubing Market

Global Medical Tubing Market

Global Gene Silencing Market

Global Gene Silencing Market

Europe Veterinary 3D Printing Market

Europe Veterinary 3D Printing Market

Global Beauty Supplements Market

Global Beauty Supplements Market

Global Human Organoid Market

Global Human Organoid Market

Stats And Research ™ Copyright © 2025 .